Moderator: - Sari Westermarck, Community pharmacist FIP Community Pharmacy Section, Finland Panellists: - Eleftherios Marinos, General Secretary-Federation of Pharmacists Cooperatives of Greece, Greece - Ahmad Al-Rusasi, General manager/Lecturer Alnoor Drug Store, Jordan - Sham Moodley, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa - Susan ODwyer, Head of Governance and Pharmacy Service, Irish Pharmacy Union, Ireland - Lus Loureno, President of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society, Portuguese Pharmaceutical Society, Portugal Watch video Digital event video 5 December 2022, 13:00 - 14:00 CET Accelerating Pharmaceutical Science: innovating and collaborating to fight COVID-19 and future pandemics More The COVID-19 pandemic is one of the greatest public health emergencies of our time
But I want all my patients and the public to know that the appetite and weight loss effects do not last forever
Industry stakeholders must prioritize affordability and sustainability, expanding production and distribution models that serve underserved populations
semaglutide (injectable) suppresses appetite and alters reward responses while active, but when it stops the body often increases hunger signals, retains lower resting energy expenditure, and re-sensitizes food reward pathways, creating a biological pull back toward prior weight
In our research, we used the subcutaneous adipose tissue cell model (Chub-S7 cells) due to the small number of publications in this field
Every plan starts with a conversation, no pressure, no guesswork
